The real-world safety and effectiveness of ocrelizumab in patients with primary progressive multiple sclerosis - a confidence study interim analysisM. Buttmann, S. Meuth,M. Weber, P. Dirks, J. Eggebrecht, S. Hieke-Schulz, J. Leemhuis,T. ZiemssenMULTIPLE SCLEROSIS JOURNAL（2022）引用 0|浏览11暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
